MedTrace Logo

Novel Point-of-Care Diagnostic Test for SARS-CoV-2 (COVID-19)

NCT04513990 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 257

Last updated 2021-12-22

No results posted yet for this study

Summary

This study investigates a new diagnostic test in detecting SARS-CoV-2, the virus that causes the disease COVID-19. This may help to improve testing for COVID-19.

Conditions

  • COVID-19 Infection

Interventions

PROCEDURE

Biospecimen Collection

Undergo collection of nasopharyngeal, oral, saliva, and nasal samples

OTHER

Questionnaire Administration

Demographic information, sample collection type preferences; clinical outcome information

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • William Marsh Rice University

    collaborator OTHER

  • M.D. Anderson Cancer Center

    lead OTHER

Principal Investigators

  • Kathleen M Schmeler · M.D. Anderson Cancer Center

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-04-09
Primary Completion
2023-04-30
Completion
2023-04-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04513990 on ClinicalTrials.gov